Data integrity is foundational. Without it, regulatory confidence erodes quickly.

Across regulated industries, inspectors rely on data to understand how decisions are made, how risks are controlled, and whether quality systems function as intended. When data cannot be trusted, the strength of every conclusion built on that data is called into question.

This is why data integrity remains a priority during inspections conducted by Health Canada and the U.S. Food and Drug Administration.

What Regulators Mean by Data Integrity

Data integrity is not limited to electronic systems. It applies equally to paper records, hybrid environments, and manual processes.

Regulators expect data to be attributable, legible, contemporaneous, original, and accurate. These principles, often grouped under the ALCOA framework, form the baseline for regulatory expectations and are reinforced through Health Canada’s Good Manufacturing Practices guidance

Over time, expectations have expanded to include completeness, consistency, and availability.

The scope is intentionally broad. Raw data, intermediate calculations, audit trails, and documented decisions all fall within regulatory interest. If data supports a quality decision, regulators expect to understand how it was generated, reviewed, and protected, as outlined in Health Canada’s data integrity and good documentation practices.

How Data Integrity Failures Develop

Most data integrity failures do not occur suddenly.

They develop gradually through small, often unchallenged practices. Records are completed after the fact. Corrections are made without explanation. Supporting data cannot be retrieved easily. Over time, these behaviours become normalized.

Electronic systems introduce additional risk. Shared logins, uncontrolled spreadsheets, disabled audit trails, and inconsistent access controls are common inspection findings, particularly those cited in FDA data integrity enforcement observations. 

In these cases, regulators are less concerned with the technology itself and more concerned with how it is governed.

Why Data Integrity Is a Governance Issue

It is tempting to treat data integrity as a technical or quality assurance problem.

In reality, it is a governance issue.

Regulators assess whether organizations have clear ownership of data, defined expectations for data handling, and effective oversight mechanisms. These expectations align closely with principles outlined in ICH Q10, the Pharmaceutical Quality System. 

When leadership engagement is limited, data integrity controls weaken. Procedures may exist, but enforcement becomes inconsistent. Training becomes routine rather than meaningful. Deviations are closed without addressing underlying causes.

From a regulatory perspective, these patterns signal systemic risk.

Practices That Support Reliable Data

Organizations with strong data integrity programs tend to share common characteristics.

Documentation expectations are clear. Records are completed at the time of activity. Corrections are transparent and justified. Raw data is retained and accessible.

Electronic systems are governed intentionally. User access is role-based. Audit trails are enabled and reviewed. Spreadsheets are validated or replaced with controlled systems where appropriate, consistent with expectations outlined in FDA process validation guidance. 

Most importantly, data review is treated as a critical control point. Information is evaluated for plausibility, completeness, and consistency before it is relied upon for quality decisions.

The Human Factor in Data Integrity 

Procedures alone do not ensure data integrity. People do.

When staff understand why data integrity matters, compliance becomes more consistent. When they feel pressured to prioritize speed over accuracy, data quality suffers. When deviations are treated as failures rather than signals, issues go unreported.

Regulators are attentive to these signals. During inspections, they assess how staff describe their work and how management responds to issues, consistent with risk-based expectations described in ICH Q9, Quality Risk Management

Culture is observable, and regulators evaluate it accordingly.

Data Integrity Across the Lifecycle

Data integrity obligations do not end at product release.

They extend through manufacturing, distribution, and post-market activities. Complaint handling, stability programs, change control, and ongoing monitoring all depend on reliable data.

Lifecycle continuity is emphasized throughout ICH Q10 and supporting guidance. Data generated early must remain traceable and usable as products evolve. When information is fragmented or lost, the ability to demonstrate control diminishes.

Regulators expect continuity. Breaks in the data trail raise questions.

Inspection Reality

During inspections, data integrity is rarely assessed in isolation.

Inspectors examine how data supports decisions. They look for alignment between records, procedures, and outcomes. They test whether data can be retrieved and explained without reconstruction.

When data integrity is strong, inspections tend to proceed efficiently. When it is weak, scrutiny increases quickly.

This reflects a simple regulatory truth. Unreliable data undermines confidence in every other control.

How MCS Associates Supports Data Integrity

At MCS Associates, we approach data integrity as a reflection of overall system maturity.

We work with organizations to review documentation practices, assess electronic and paper-based systems, and strengthen governance around data generation and review. We also support inspection readiness by helping clients demonstrate how data is controlled across functions.

The objective is not perfection. It’s defensibility.

Data Integrity as a Measure of Maturity

Regulators view data integrity as an indicator of how an organization operates.

Reliable data supports defensible decisions, reduces inspection risk, and strengthens confidence across the regulatory relationship. Organizations that invest in data integrity reduce exposure across every aspect of compliance.

Talk to the team at MCS Associates to see how we can help ensure that data supports your systems rather than undermining them.

Resources:

Related Posts